Page last updated: 2024-08-16

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and morphine

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with morphine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19907 (70.00)18.7374
1990's3 (30.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET1
Collier, HO; Francis, DL; Roy, AC1
Daly, JW; Dismukes, K1
Nicholson, D; Reid, A; Sawynok, J1
Nicholson, D; Sawynok, J; White, TD1
Butler, JM; Chan, SC; Ebertz, M; Hanifin, JM; Sobieszczuk, D; Stevens, SR1
Holtzman, SG1
Haigler, HJ; Hosford, DA1
Narahashi, T; Tsunoo, A1
Coyle, TS; Kaplan, GB1

Other Studies

10 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and morphine

ArticleYear
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium

1985
Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
    Life sciences, 1975, Jun-15, Volume: 16, Issue:12

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Male; Morphine; Naloxone; Phosphodiesterase Inhibitors; Prostaglandins; Rats; Structure-Activity Relationship; Substance Withdrawal Syndrome; Theophylline; Time Factors; Xanthines

1975
Accumulation of adenosine 3',5'-monophosphate in rat brain slices: effects of prostaglandins.
    Life sciences, 1975, Jul-15, Volume: 17, Issue:2

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Animals; Brain; Catecholamines; Cerebellum; Cerebral Cortex; Corpus Striatum; Cyclic AMP; Dose-Response Relationship, Drug; Guinea Pigs; Hippocampus; Hypothalamus; Isoproterenol; Male; Medulla Oblongata; Mesencephalon; Morphine; Naloxone; Phentolamine; Pons; Prostaglandin Antagonists; Prostaglandins; Prostaglandins A; Prostaglandins E; Prostaglandins F; Rats; Thalamus; Time Factors; Veratridine

1975
Effects of forskolin and phosphodiesterase inhibitors on spinal antinociception by morphine.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 38, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Colforsin; Cyclic AMP; Injections, Spinal; Male; Morphine; Nociceptors; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Spinal Cord

1991
Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes.
    Canadian journal of physiology and pharmacology, 1991, Volume: 69, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 5'-Nucleotidase; Adenosine; Animals; Colforsin; Cyclic AMP; In Vitro Techniques; Morphine; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rolipram; Spinal Cord; Synaptosomes

1991
Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
    Acta dermato-venereologica. Supplementum, 1985, Volume: 114

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Basophils; Carbachol; Concanavalin A; Cyclic AMP; Dermatitis, Atopic; Histamine Release; Humans; Leukocytes; Methacholine Compounds; Morphine; Phosphoric Diester Hydrolases; Stimulation, Chemical

1985
Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 33, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Body Weight; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Male; Morphine; Naltrexone; Narcotic Antagonists; Papaverine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders

1989
Cyclic AMP, morphine, met-enkephalin and neuronal firing.
    The Journal of pharmacology and experimental therapeutics, 1981, Volume: 219, Issue:2

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Action Potentials; Animals; Cyclic AMP; Endorphins; Enkephalin, Methionine; Enkephalins; Male; Mesencephalon; Morphine; Neurons; Pain; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains

1981
Cyclic AMP-mediated potentiation of muscarinic hyperpolarization in neuroblastoma cells.
    Brain research, 1984, Feb-27, Volume: 294, Issue:1

    Topics: 2-Chloroadenosine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Acetylcholine; Adenosine; Alprostadil; Animals; Cyclic AMP; Dopamine; In Vitro Techniques; Iontophoresis; Membrane Potentials; Mice; Morphine; Muscarine; Neuroblastoma; Prostaglandins E

1984
Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation.
    European journal of pharmacology, 1998, Nov-27, Volume: 362, Issue:1

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine Kinase; Animals; Body Weight; Caffeine; Deoxyadenosines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mice; Morphine; Receptors, Purinergic P1; Substance Withdrawal Syndrome

1998